Trends in Morbidities of Late Preterm Infants in the Neonatal Intensive Care Unit

doi:10.21203/rs.3.rs-2224059/v1

Download PDF

Article

Trends in Morbidities of Late Preterm Infants in the Neonatal Intensive Care Unit

https://doi.org/10.21203/rs.3.rs-2224059/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 01 Jul, 2023

Read the published version in Journal of Perinatology →

You are reading this latest preprint version

Objective

To characterize demographics and trends in length of stay (LOS), morbidities, and mortality in late preterm infants.

Study design

Cohort study of infants born between 34 ^0/7 and 36 ^6/7 weeks gestation between 1999 and 2018 without major congenital anomalies at Pediatrix Medical Group neonatal intensive care units (NICUs).

Results

307 967 infants from 410 NICUs met inclusion criteria. The median (25th -75th percentile) LOS was 11 (8–16) days in the entire period. Postmenstrual age (PMA) at discharge increased over time for all gestational ages (p < 0.001). There was a decrease in invasive ventilation, receipt of phototherapy, and reflux medications observed (p < 0.001).

Conclusion

In this large cohort, late preterm infants had an increased PMA at discharge and no significant improvement in LOS during the study period. Multiple practice changes were observed. There continue to be opportunities to improve morbidities among late preterm infants and to potentially decrease hospital stays.

Health sciences/Medical research/Epidemiology

Health sciences/Medical research/Outcomes research

Health sciences/Health care/Paediatrics

The late preterm infant, born between 34^0/7 and 36^6/7 weeks, is an important focus of research and advancement in neonatology ¹. While late preterm infants experience less mortality than those born prior to 34 weeks, they are still at risk of significant morbidities ^2,3. This can be distressing for parents as they are often anxious to take home what they perceive is just a small term infant ⁴.

The prevalence of late preterm deliveries has continued to rise over the past few years, increasing the number of admissions in this already large neonatal intensive care unit (NICU) population ⁵. In 2019, late preterm births accounted for 7.5% of all deliveries in the United States, up from 6.8% in 2014 ^5,6. The increase in late preterm births is thought to be due in part to increasing maternal age and use of assisted reproductive technology ⁷. The rising volume of preterm infants places strain on hospital systems, increases the number of hospital days and results in increased healthcare costs. The cost associated with preterm birth can be as much as 5 times higher than infants born at term ⁸. Common problems seen in late preterm infants include: feeding difficulties, respiratory distress, hypoglycemia, hyperbilirubinemia, and temperature instability ^4,8,9. In one prior retrospective cohort study including 235 late preterm infants, these disorders were severe enough to require intervention, therefore prolonging stay, in roughly 30% of infants ⁴.

The purpose of this study was to evaluate how length of hospital stay and morbidities have changed for late preterm infants over a 20-year time period.

Study design

We performed a cohort study of infants discharged between 1999–2018 at Pediatrix Medical Group NICUs. The Pediatrix database includes infants discharged from over 400 NICUs in the United States and Puerto Rico. Information from daily notes is extracted, de-identified, and compiled into the Pediatrix BabySteps Clinical Data Warehouse ¹⁰. The available extracted information includes maternal and infant demographics, laboratory results, including blood, urine, and spinal fluid culture results, medications, diagnoses, and other clinical data.

We excluded infants with major congenital anomalies, outborn infants, or those transferred to a higher level of care. We divided infants into 2 eras (1999–2008 and 2009–2018) based on year of hospital discharge and evaluated trends in length of stay (LOS). Primary outcomes of interest included number of admissions over time, LOS, post-menstrual age (PMA) at discharge, the presence of diagnoses including hypoglycemia, hyperbilirubinemia, sepsis, receipt of respiratory support, and death before discharge.

Definitions

We defined late preterm infants as those born between 34^0/7 weeks and 36^6/7 weeks. We defined large for gestational age as an infant with a weight greater than or equal to the 90th percentile for gestational age and small for gestational age as an infant with a weight less than or equal to the 10th percentile for gestational age using the Olsen curves ¹¹. We defined hypoglycemia as any blood glucose less than 45 mg/dL. We defined respiratory distress syndrome (RDS) by either documentation in clinician notes or the receipt of any surfactant. We defined thrombocytopenia as platelet count less than 50 000/microL. We defined early onset sepsis as a positive blood culture within the first three days of age, excluding skin contaminants [including non-speciated streptococci, Bacillus sp., Micrococcus sp., gram-positive rods (not including Listeria sp.), Lactobacillus sp., Stomatococcus sp., Propionibacterium sp., Corynebacterium sp., Bacteroides sp., and diptheroids sp.]^12,13. We defined late onset sepsis as a positive blood culture after 3 days of age, excluding the same skin contaminants, and meningitis as any positive cerebrospinal fluid culture, also excluding common skin contaminants. We defined urinary tract infection as any positive urine culture. We defined pneumonia by clinical documentation. We defined the use of reflux medications as any receipt of proton pump inhibitors or H2 blockers. We defined respiratory support as the receipt of nasal cannula, oxyhood, continuous positive airway pressure (CPAP), noninvasive positive-pressure ventilation (NIPPV), conventional mechanical ventilation, or high frequency ventilation (jet or oscillator). We defined necrotizing enterocolitis (NEC) as the diagnosis of either surgical or medical NEC, as documented in clinician notes. We considered all of the above complications or interventions to be morbidities.

Statistical methods

We used the chi-square test to compare demographics and morbidities between the two eras. The chi-square test was also used to compare morbidities between the gestational ages (GAs), 34 weeks, 35 weeks, and 36 weeks. Descriptive statistics such as frequencies and percentages were calculated for categorical variables, and median with interquartile ranges for continuous variables. Wilcoxon rank sum was used to determine significance for continuous variables. P-values < 0.05 were considered to be significant. All analyses were conducted using Stata 17.0 (College Station, TX).

307 967 infants from 410 NICUs met the inclusion criteria, including 110 993 infants in the first era (1999–2008) and 196 974 in the second (2009–2018), 29% of all infants studied. While there was an overall increase in the absolute number of late preterm infants over the study period, it was driven by an overall increase in the number of NICUs and infants for whom Pediatrix provided care (Fig. 1). The relative percent of NICU patients that were late preterm remained constant between 26–31% of all NICU admissions. Among late preterm infants, the median (25th -75th percentile) for GA was 35 (34–36) weeks. The majority of infants included were born at 34 weeks (Fig. 1). The median birth weight was 2355 (2070–2671) grams and the majority of infants were male, 55%. There was an increase in the percentage of Black infants in the second era, from 15–19% (p < 0.001, Table 1).

Table 1

Demographics by time period, 1999–2018
Demographics	1999–2008	2009–2018	p-value¹
Demographics	(N = 110 993)	(N = 196 974)	p-value¹
Gestational age, weeks, n (%)			< 0.001
34^0/7 – 34^6/7	45 762 (41)	81 605 (41)
35^0/7 – 35^6/7	36 050 (32)	61 942 (31)
36^0/7 – 36^6/7	29 181 (26)	53 427 (27)
Male, n (%)	61 695 (56)	108 023 (55)	< 0.001
Race/Ethnicity, n (%)			< 0.001
White	59 652 (56)	97 800 (53)
Black	16 305 (15)	34 746 (19)
Hispanic	24 850 (23)	40 679 (22)
Other	5818 (5)	11 994 (6)
Birth weight (grams), n (%)			< 0.001
<1500	1860 (2)	2933 (1)
1500–2499	67 177 (61)	120 095 (61)
>2499	41 852 (38)	73 944 (38)
Premature or prolonged rupture of membranes, n (%)	11 338 (11)	20 530 (10)	0.39
Received antenatal steroids, n (%)	24 989 (23)	67 208 (34)	< 0.001
Positive maternal GBS status, n (%)	11 558 (10)	22 389 (11)	< 0.001
Small for gestational age, n (%)	13 588 (12)	24 711 (13)	0.02
Large for gestational age, n (%)	8699 (8)	15 966 (8)	0.01
Death before discharge, n (%)	231 (0.2)	275 (0.14)	< 0.001
Length of hospitalization, days (median (IQR))
All late preterm infants	10 (7, 15)	11 (8, 16)	< 0.001
34^0/7 – 34^6/7	13 (9, 17)	14 (10, 19)
35^0/7 – 35^6/7	10 (7, 14)	11 (7, 15)
36^0/7 – 36^6/7	8 (6, 11)	8 (6, 12)
PMA at discharge, weeks (median (IQR))
All late preterm infants	36.6 (35.9, 37.1)	36.9 (36.1, 37.6)	< 0.001
34^0/7 – 34^6/7	35.9 (35.3, 36.6)	36.3 (35.7, 37.0)
35^0/7 – 35^6/7	36.4 (36.0, 37.0)	36.9 (36.3, 37.4)
36^0/7 – 36^6/7	37.3 (36.9, 37.7)	37.4 (37.1, 38.0)
¹ p-value calculated by chi-squared test
GBS: Group B Streptococcus; IQR: interquartile range; PMA: postmenstrual age

The median (25th -75th percentile) LOS for the entire study period was 11 days (8–16), with an increase from 10 days to 11 days in the later era (Table 1, p < 0.001). Increased LOS was observed for both the 34-week and 35-week infants (Table 1, Fig. 2). PMA at discharge increased over time for all GAs (p < 0.001, Table 1, Fig. 2). The median PMA at discharge was 36–37 weeks for the entire study period (Table 1).

Mortality was low throughout the study period, 0.2% in the first era and 0.14% in the second (Table 1). The most common morbidities experienced by infants were receipt of phototherapy, receipt of respiratory support, and RDS, and all were more likely in the 34-week infants (Table 2, 3). There was no difference in the incidence of hypoglycemia (p = 0.002) or serious infections such as sepsis (p < 0.001) across GAs (Table 3).

Table 2

Morbidities by time period, 2010–2018
Morbidities of interest	1999–2008 (N = 110 993)	2009–2018 (N = 196 974)	p-value¹
Early onset sepsis, n (%)	424 (0.4)	595 (0.3)	< 0.001
Late onset sepsis, n (%)	280 (0.3)	265 (0.1)	< 0.001
Meningitis, n (%)	21 (0.02)	42 (0.02)	0.65
Pneumonia, n (%)	2262 (2)	2019 (1)	< 0.001
Urinary tract infection, n (%)	228 (0.2)	276 (0.1)	< 0.001
Necrotizing enterocolitis, n (%)	465 (0.4)	477 (0.2)	< 0.001
Hypoglycemia, n (%)	9300 (8)	12 855 (7)	< 0.001
Thrombocytopenia, n (%)	1758 (2)	2550 (1)	< 0.001
Receipt of phototherapy, n (%)	51 460 (46)	76 199 (39)	< 0.001
Anti-reflux medications, n (%)	3227 (3)	2062 (1)	< 0.001
H2 blockers	2842 (3)	1367 (1)	< 0.001
Proton pump inhibitors	490 (0.4)	852 (0.4)	0.72
Receipt of caffeine, n (%)	4646 (4)	7457 (4)	< 0.001
Respiratory distress syndrome, n (%)	21 365 (19)	37 355 (19)	0.05
Received surfactant, n (%)	12 846 (12)	17 881 (9)	< 0.001
Respiratory support, n (%)	59 173 (53)	101 831 (52)	< 0.001
Oxyhood, n (%)	10 288 (9)	3058 (2)	< 0.001
Nasal cannula, n (%)	8347 (8)	11 327 (6)	< 0.001
High flow nasal cannula, n (%)	8031 (7)	28 085 (14)	< 0.001
Continuous positive airway pressure, n (%)	19 413 (18)	44 180 (22)	< 0.001
Noninvasive positive-pressure ventilation, n (%)	197 (0.2)	3780 (2)	< 0.001
Conventional mechanical ventilation, n (%)	11 970 (11)	10 651 (5)	< 0.001
High frequency ventilator, n (%)	927 (1)	750 (0.4)	< 0.001
¹ p-value calculated by chi-squared test

Table 3

Morbidities by gestational age, 1999–2018
Morbidities of interest	34^0/7 – 34^6/7 (N = 127 367)	35^0/7 – 35^6/7 (N = 97 992)	36^0/7 – 36^6/7 (N = 82 608)	p-value¹
Early onset sepsis, n (%)	411 (0.3)	278 (0.3)	330 (0.4)	< 0.001
Late onset sepsis, n (%)	279 (0.2)	153 (0.2)	113 (0.1)	< 0.001
Meningitis, n (%)	34 (0.03)	9 (0.01)	20 (0.02)	0.01
Pneumonia, n (%)	895 (1)	1 351 (1)	2 035 (2)	< 0.001
Urinary tract infection, n (%)	220 (0.2)	158 (0.2)	126 (0.2)	0.52
Necrotizing enterocolitis, n (%)	517 (0.4)	286 (0.3)	139 (0.2)	< 0.001
Hypoglycemia, n (%)	9374 (7)	6836 (7)	5945 (7)	0.002
Thrombocytopenia, n (%)	1735 (1)	1321 (1)	1252 (2)	0.004
Receipt of phototherapy, n (%)	61 868 (49)	38 630 (39)	27 161 (33)	< 0.001
Anti-reflux medications, n (%)	2247 (2)	1615 (2)	1427 (2)	0.11
H2 blockers	1748 (1)	1290 (1)	1171 (1)	0.18
Proton pump inhibitors	605 (0.5)	416 (0.4)	321 (0.4)	0.01
Respiratory distress syndrome, n (%)	25 282 (20)	18 913 (19)	14 525 (18)	< 0.001
Received surfactant, n (%)	12 554 (9.9)	10 135 (10.3)	8 038 (9.7)	< 0.001
Respiratory support, n (%)	64 358 (51)	51 721 (53)	44 925 (54)	< 0.001
Oxyhood	4 161 (3)	4 471 (5)	4 714 (6)	< 0.001
Nasal cannula	7306 (6)	6404 (7)	5964 (7)	< 0.001
High flow nasal cannula	13 846 (11)	11 567 (12)	10 703 (13)	< 0.001
Continuous positive airway pressure	27 761 (22)	20 108 (21)	15 724 (19)	< 0.001
Noninvasive positive-pressure ventilation	1795 (1)	1186 (1)	996 (1)	< 0.001
Conventional mechanical ventilation	8865 (7)	7450 (8)	6306 (8)	< 0.001
High frequency ventilator	624 (0.5)	535 (0.6)	518 (0.6)	< 0.001
¹ p-value calculated by chi-squared test

Between the two eras, receipt of antenatal steroids increased from 23–34% (Table 1, p < 0.001). The percent of infants receiving surfactant was consistent among all gestational ages at about 10% (Table 3). Surfactant use decreased between the two eras, going from 12–9% (p < 0.001, Table 2). While overall receipt of respiratory support remained consistent between the two eras, there was a significant increase in less invasive ventilation in era 2 (2009–2018). The receipt of HFNC increased from 7–14% and NIPPV increased tenfold (0.2–2%, p < 0.001, Table 2). Fewer infants received either conventional or high frequency ventilation in the more recent era (Table 2).

The use of anti-reflux medications decreased significantly from 3–1% between the eras (p < 0.001) (Table 2). The duration of reflux medication use was 3 days (1, 6). There was no significant difference in use across GAs (Table 3, p = 0.106). Caffeine use stayed stable at 4% across eras (Table 2, p < 0.001). The median duration of caffeine for the cohort was 3 days (1, 8). Phototherapy use decreased from 46–39% between the two eras (Table 2).

In this large cohort of infants across the United States, we found that the length of hospital admission for late preterm infants has increased over the past twenty years. The median LOS increased by one day for the full cohort, with the change particularly seen in the 34-week and 35-week infants. The most common morbidities were the receipt of respiratory support, receipt of phototherapy, RDS, and hypoglycemia, similar to previous findings ^4,14,15. As would be expected, hyperbilirubinemia and RDS were more prevalent in the 34-week infants ⁹. We also noted important practice changes over the 20-year period, including a decrease in invasive ventilation, increase in antenatal steroid use, decrease in phototherapy use, and decrease in reflux medication use.

Multiple studies have evaluated hospitalizations in this group but with a large variety in definitions surrounding LOS and inclusion criteria, making comparison somewhat difficult ^{4, 14–19}. At some centers, 35–36 week infants may be admitted to a full-term nursery or intermediate level nursery and are included in the analysis as well. Previous work in a Toronto area study reported a LOS for infants admitted to the NICU at 8 days, which was slightly lower than our finding of 11 days, with 45% of their late preterm population requiring NICU care ¹⁴. Another study that included intermediate nursery patients reported an overall LOS of about 6 days ⁴. A similarly sized study from the Vermont Oxford Network only commented on the frequency of short stays (under 3 days), which was 10% in the late preterm group ¹⁸. Our observed LOS is likely in part due to our inclusion criteria, as we included infants requiring a NICU stay who may be sicker at baseline than infants with less comorbidities who qualify for a lower level of care. When previously measured in national and international single center retrospective trials, the percent of late preterm infants that required the NICU for at least part of their stay had a large amount of variation, from 20–55% ^4,14,20,21. Information about infants admitted to other units would be helpful in accurately determining LOS for the age group as a whole, as they may discharge with their mothers at 2–3 days ¹⁵.

The trend towards increasing LOS in our study was unexpected, given the improvements and technological advancements in the NICU over the time period. Our finding may be in part due to hesitation to discharge infants too early due to the risk of readmission, which is historically higher in the late preterm cohort overall ³. Prior studies have shown that the most common causes for readmission in the late preterm age group are hyperbilirubinemia and feeding difficulties ²². Because of this, late preterm infants are not discharged until they are consistently demonstrating weight gain with feeds, which is a different bar than term infants. This hesitation to discharge may be somewhat unwarranted, with recent studies demonstrating no correlation between longer stays and reduced readmission ^22,23. We found that all GAs of infants in the cohort were discharged at about the same postmenstrual age, around 36–37 weeks. This is consistent with a prior study from 2021 in which a similar population was evaluated, and aligns with the expected GA for feeding maturity ^24–26.

Several important changes in practice occurred over the past 20 years for this cohort of infants. One was a statistically significant increase in the number of infants that received antenatal steroids (from 23% in era 1 to 34% in era 2, p < 0.001). Of note, the infants included in this cohort were born outside the previously recommended range for antenatal steroids from the American College of Obstetricians and Gynecologists, which stops at 33^6/7, meaning the more premature infants or those whose mother was previously in preterm labor are more likely to have received them ²⁷. The increase in steroid use in the more recent era may be reflective of trials such as the Antenatal Late Preterm Steroids (ALPS) trial, which were occurring during the study period and demonstrated improvement in respiratory outcomes in the late preterm group with steroid administration ²⁸. This increase in steroid use could also have contributed to the observed increase in non-invasive ventilation, and a subsequent decrease in invasive ventilation in our study. These trends may also represent practice changes towards minimizing invasive ventilation ²⁹. Similarly, the decrease in surfactant use in our study may be due to improved respiratory outcomes with increasing steroids, or from the additional barrier to administration in non-intubated infants.

Our study also demonstrated a decrease in acid reflux medication use, particularly in H2 blockers. There has been emerging evidence of the lack of efficacy of acid suppression treatment, and the risks associated with acid suppression, which may have influenced this change ^30–32. We also noted a decrease in the use of phototherapy, likely influenced by consensus statements on safe bilirubin levels in this cohort, and the introduction of tools such as the Stanford Premie BiliRecs ^33,34. The use of phototherapy was associated with a longer stay, and may be a target of intervention to assist with an earlier hospital discharge ³⁵.

A significant strength of this study was the large sample size, which was able to be measured consistently over 20 years from a variety of centers, making a good representative population. However, there were multiple limitations to this study. Due to the method of data collection, we were unable to study issues related to feeding. Invasive devices like nasogastric and orogastric tubes were not recorded for the cohort, and percent of oral feeds were not able to be collected. We were unable to determine if feeding volumes were limiting hospital discharge or if an infant was discharged home on tube feeds. We were also unable to identify which infants had temperature instability. As previously mentioned, this cohort does not capture the infants that were admitted to other units in the hospital outside of the NICU, such as the mother-baby unit. This limits the ability to extrapolate data to the age group, since those infants are likely healthier and discharge earlier. This study also does not capture information regarding hospital readmissions, a common concern with early discharge.

In conclusion, in this study of late preterm infants over a 20-year period, we helped to define the status of NICU late preterm care for the past two decades and demonstrate areas where there are still opportunities for advancement. We were able to show when infants discharged in this time period leave the hospital and the major problems that they face that may prolong their stay. There continues to be room for improvement to safely discharge these infants earlier and to decrease the burden of their stay on the medical system and their families.

ACKNOWLEDGEMENTS

This research was supported in part by the Duke Pediatric Research Scholars Program, Department of Pediatrics, Duke University School of Medicine

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

AUTHOR CONTRIBUTIONS

All authors were involved in the study design, analysis, and manuscript revision. All authors read and approved the final manuscript. Dr. Lockyear is the guarantor who accepts full responsibility for the work and the conduct of the study, has access to the data, and controlled the decision to publish.

C Lockyear: Dr. Lockyear contributed to the conception and design of the study, the data interpretation, the manuscript drafting, and the critical revision of the manuscript.

K Coe: Dr. Coe contributed to the conception and design of the study, the data interpretation, and the critical revision of the manuscript.

RH Clark: Dr. Clark contributed to the conception and design of the study, the data acquisition, the data interpretation, and the critical revision of the manuscript.

RG Greenberg: Dr. Greenberg contributed to the conception and design of the study, the data analysis and interpretation, and the critical revision of the manuscript.

S Aleem: Dr. Aleem had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Aleem contributed to the conception and design of the study, the data analysis, the data interpretation, and the critical revision of the manuscript.

FUNDING INFORMATION

The authors did not receive funding for this study.

Raju TNK. The problem of late-preterm (near-term) births: a workshop summary. Pediatr Res. 2006;60(6):775–776. doi:10.1203/01.pdr.0000246074.73342.1e
Williams JE, Pugh Y. The Late Preterm: A Population at Risk. Crit Care Nurs Clin North Am. 2018;30(4):431–443. doi:10.1016/j.cnc.2018.07.001
Tomashek KM, Shapiro-Mendoza CK, Weiss J, et al. Early Discharge Among Late Preterm and Term Newborns and Risk of Neonatal Morbidity. Seminars in Perinatology. 2006;30(2):61–68. doi:10.1053/j.semperi.2006.02.003
Pulver LS, Denney JM, Silver RM, Young PC. Morbidity and discharge timing of late preterm newborns. Clinical Pediatrics. 2010;49(11):1061–1067. doi:10.1177/0009922810376821
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51.
Hamilton BE, Martin JA, Osterman MJK, Curtin SC, Matthews TJ. Births: Final Data for 2014. Natl Vital Stat Rep. 2015;64(12):1–64.
Mally PV, Bailey S, Hendricks-Muñoz KD. Clinical Issues in the Management of Late Preterm Infants. Current Problems in Pediatric and Adolescent Health Care. 2010;40(9):218–233. doi:10.1016/j.cppeds.2010.07.005
Horgan MJ. Management of the late preterm infant: not quite ready for prime time. Pediatr Clin North Am. 2015;62(2):439–451. doi:10.1016/j.pcl.2014.11.007
Karnati S, Kollikonda S, Abu-Shaweesh J. Late preterm infants - Changing trends and continuing challenges. Int J Pediatr Adolesc Med. 2020;7(1):36–44. doi:10.1016/j.ijpam.2020.02.006
Spitzer AR, Ellsbury D, Clark RH. The Pediatrix BabySteps® Data Warehouse–a unique national resource for improving outcomes for neonates. Indian J Pediatr. 2015;82(1):71–79. doi:10.1007/s12098-014-1585-2
Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on United States data. Pediatrics. 2010;125(2):e214-224. doi:10.1542/peds.2009-0913
Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817–826. doi:10.1542/peds.2010-2217
Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88 Suppl 2:S69-74. doi:10.1016/S0378-3782(12)70019-1
Jefferies AL, Lyons ER, Shah PS, Shah V. Impact of late preterm birth on neonatal intensive care resources in a tertiary perinatal center. Am J Perinatol. 2013;30(7):573–578. doi:10.1055/s-0032-1329685
Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics. 2004;114(2):372–376. doi:10.1542/peds.114.2.372
Aly H, Hoffman H, El-Dib M, Said L, Mohamed M. Factor affecting length of stay in late preterm infants: an US national database study. J Matern Fetal Neonatal Med. 2015;28(5):598–604. doi:10.3109/14767058.2014.927428
Celik IH, Demirel G, Canpolat FE, Dilmen U. A common problem for neonatal intensive care units: late preterm infants, a prospective study with term controls in a large perinatal center. J Matern Fetal Neonatal Med. 2013;26(5):459–462. doi:10.3109/14767058.2012.735994
Edwards EM, Horbar JD. Variation in Use by NICU Types in the United States. Pediatrics. 2018;142(5). doi:10.1542/peds.2018-0457
Boyle EM, Johnson S, Manktelow B, et al. Neonatal outcomes and delivery of care for infants born late preterm or moderately preterm: a prospective population-based study. Arch Dis Child Fetal Neonatal Ed. 2015;100(6):F479-485. doi:10.1136/archdischild-2014-307347
Kitsommart R, Janes M, Mahajan V, et al. Outcomes of late-preterm infants: a retrospective, single-center, Canadian study. Clin Pediatr (Phila). 2009;48(8):844–850. doi:10.1177/0009922809340432
Melamed N, Klinger G, Tenenbaum-Gavish K, et al. Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol. 2009;114(2 Pt 1):253–260. doi:10.1097/AOG.0b013e3181af6931
Moyer LB, Goyal NK, Meinzen-Derr J, et al. Factors associated with readmission in late-preterm infants: a matched case-control study. Hosp Pediatr. 2014;4(5):298–304. doi:10.1542/hpeds.2013-0120
Goyal N, Zubizarreta JR, Small DS, Lorch SA. Length of stay and readmission among late preterm infants: an instrumental variable approach. Hosp Pediatr. 2013;3(1):7–15. doi:10.1542/hpeds.2012-0027
Joyce AH, Sengupta A, Garfield CF, Myers P. When is My Baby Going Home? Moderate to Late Preterm Infants are Discharged at 36 Weeks Based on Admission Data. Am J Perinatol. 2021;38(8):773–778. doi:10.1055/s-0039-3401850
Lau C. Development of infant oral feeding skills: what do we know?123. Am J Clin Nutr. 2016;103(2):616S-621S. doi:10.3945/ajcn.115.109603
Simpson C, Schanler RJ, Lau C. Early Introduction of Oral Feeding in Preterm Infants. Pediatrics. 2002;110(3):517–522. doi:10.1542/peds.110.3.517
Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017;130(2):e102-e109. doi:10.1097/AOG.0000000000002237
Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311–1320. doi:10.1056/NEJMoa1516783
COMMITTEE ON FETUS AND NEWBORN, Papile LA, Baley JE, et al. Respiratory Support in Preterm Infants at Birth. Pediatrics. 2014;133(1):171–174. doi:10.1542/peds.2013-3442
Wheatley E, Kennedy KA. Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants. J Pediatr. 2009;155(4):516–521. doi:10.1016/j.jpeds.2009.03.044
Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children’s Hospitals. Journal of Pediatrics. 2016;1:63–70. doi:10.1016/j.jpeds.2016.03.059
Beck-Sague CM, Azimi P, Fonseca SN, et al. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J. 1994;13(12):1110–1116.
Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32(9):660–664. doi:10.1038/jp.2012.71
Palma JP, Arain YH. Development of a Web-Based Decision Support Tool to Operationalize and Optimize Management of Hyperbilirubinemia in Preterm Infants. Clinics in Perinatology. 2016;43(2):375–383. doi:10.1016/j.clp.2016.01.009
Chang PW, Waite WM. Evaluation of Home Phototherapy for Neonatal Hyperbilirubinemia. J Pediatr. 2020;220:80–85. doi:10.1016/j.jpeds.2020.01.004

There is NO conflict of interest to disclose.

Download PDF

Journal Publication

published 01 Jul, 2023

Read the published version in Journal of Perinatology →

Editorial decision: revise
05 Dec, 2022
Review #1 received at journal
03 Dec, 2022
Review #2 received at journal
24 Nov, 2022
Reviewer #2 agreed at journal
06 Nov, 2022
Reviewer #1 agreed at journal
04 Nov, 2022
Reviewers invited by journal
04 Nov, 2022
Submission checks completed at journal
01 Nov, 2022
First submitted to journal
31 Oct, 2022
Editor assigned by journal
31 Oct, 2022

You are reading this latest preprint version

Trends in Morbidities of Late Preterm Infants in the Neonatal Intensive Care Unit

Status:

Journal Publication

Version 1

Abstract

Objective

Study design

Results

Conclusion

Figures

Introduction

METHODS

Study design

Definitions

Statistical methods

Results

Discussion

Declarations

References

Additional Declarations

Status:

Journal Publication

Version 1